Physician profile
Dwight C De Risi
NPI 1902876204
$1,376.24
in general payments reported to CMS, 2019-2025
10 companies · $52.89 in 2025
The $52.89 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $285 · 2021: $109 · 2022: $118 · 2023: $126 · 2024: $98.23 · 2025: $52.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $714.65 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $315.63 | 2019-2025 | Caldolor |
| Tactile Systems Technology INC | $143.08 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $66.83 | 2019-2024 | Verquvo, Bridion |
| Kite Pharma, INC. | $28.40 | 2021 | |
| Genzyme Corporation | $27.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.42 | 2019 | |
| Axogen | $21.77 | 2022 | |
| Chiesi USA, INC. | $20.28 | 2019 | |
| Hologic Sales and Service, LLC | $13.67 | 2023 | Trunode, Trident Specimen Radiography System, Localizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight De Risi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.